Literature DB >> 1948228

Neuroleptic malignant syndrome associated with carbamazepine.

F M O'Griofa1, J C Voris.   

Abstract

We have described the case of a patient who had symptoms of the neuroleptic malignant syndrome after treatment with carbamazepine. The symptoms resolved after carbamazepine therapy was stopped, which suggests carbamazepine as their cause.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1948228     DOI： 10.1097/00007611-199111000-00023

Source DB:  PubMed          Journal:  South Med J        ISSN： 0038-4348            Impact factor:   0.954


  2 in total

1.  Combination of Steven-Johnson syndrome and neuroleptic malignant syndrome following carbamazepine therapy: a rare occurrence.

Authors:  Bhawna Sharma; Raghavendra Bakki Sannegowda; Pankaj Gandhi; Parul Dubey; Ashok Panagariya
Journal:  BMJ Case Rep       Date:  2013-06-11

2.  Neuroleptic malignant syndrome: A diagnostic challenge.

Authors:  Reshma P Ambulkar; Vijaya P Patil; Aliasgar V Moiyadi
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.